Drugs / NK
last change Dec 2023 re-read 3 minutes ago

NK

Developed for
cancer
Investigated by
Yantai Yuhuangding Hospital

Trials 1

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT04214730 Dec 2019 → Dec 2023 cancer Yantai Yuhuangding Hospital Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as NK ClinicalTrials.gov intervention name — accepted as the source's own label NCT04214730 ↗